Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
454,877
-
Share change
-
+3,268
-
Total reported value
-
$1,841,000
-
Price per share
-
$4.04
-
Number of holders
-
9
-
Value change
-
-$14,992
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2021
As of 31 Dec 2021,
Lexaria Bioscience Corp. - COM NEW (LEXX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
454,877 shares.
The largest 9 holders included
Invenomic Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, UBS Group AG, Edge Wealth Management LLC, MD Financial Management Inc., Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, and ROYAL BANK OF CANADA.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.